GlassScriptPhysician profile
Hesham E Gayar
NPI 1962402370
$1,685.79
in general payments reported to CMS, 2019-2025
13 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $871 · 2020: $116 · 2021: $288 · 2022: $94.50 · 2023: $83.60 · 2024: $17.08 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $577.87 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $447.20 | 2019-2023 | Calquence |
| Boston Scientific Corporation | $132.12 | 2023-2025 | Spaceoar Vue System - 10ml |
| Genzyme Corporation | $121.92 | 2021 | |
| Janssen Biotech, INC. | $99.95 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.00 | 2019 | |
| Teleflex LLC | $76.01 | 2025 | Barrigel |
| Myovant Sciences INC. | $36.72 | 2021 | |
| Bioprotect Medical, INC. | $25.98 | 2025 | Bioprotect Balloon Implant System |
| Eisai INC. | $23.80 | 2025 | |
| Seagen INC. | $22.62 | 2023 | Tukysa |
| Siemens Medical Solutions USA, INC. | $17.08 | 2024 | Somatom Go.Top, Somatom X.Cite |
| Novartis Pharmaceuticals Corporation | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hesham Gayar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.